Abstract
Objective
To evaluate the interfractional variations of patient positioning during intensity-modulated radiotherapy (IMRT) with helical tomotherapy in head and neck cancer and to calculate the required safety margins (sm) for bony landmarks resulting from the necessary table adjustments.
Materials and methods
In all, 15 patients with head and neck cancer were irradiated using the Hi-Art II tomotherapy system between April and September 2016. Before therapy sessions, patient position was frequently checked by megavolt computed tomography (MV-CT). Necessary table adjustments (ta) in the right-left (rl), superior-inferior (si) and anterior-posterior (ap) directions were recorded for four anatomical points: second, fourth and sixth cervical vertebral body (CVB), anterior nasal spine (ANS). Based upon these data sm were calculated for non-image-guided radiotherapy, image-guided radiotherapy (IGRT) and image guidance limited to a shortened area (CVB 2).
Results
Based upon planning CT the actual treatment required ta from –0.05 ± 1.31 mm for CVB 2 (ap) up to 2.63 ± 2.39 mm for ANS (rl). Considering the performed ta resulting from image control (MV-CT) we detected remaining ta from –0.10 ± 1.09 mm for CVB 4 (rl) up to 1.97 ± 1.64 mm for ANS (si). After theoretical adjustment of patients position to CVB 2 the resulting ta ranged from –0.11 ± 2.44 mm for CVB6 (ap) to 2.37 ± 2.17 mm for ANS (si). These data imply safety margins: uncorrected patient position: 3.63–9.95 mm, corrected positioning based upon the whole target volume (IGRT): 1.85–6.63 mm, corrected positioning based upon CVB 2 (IGRT): 3.13–6.66 mm.
Conclusions
The calculated safety margins differ between anatomic regions. Repetitive and frequent image control of patient positioning is necessary that, however, possibly may be focussed on a limited region.
Zusammenfassung
Zielsetzung
Ziel war die Erfassung von interfraktionellen Abweichungen der Patientenlagerung während einer intensitätsmodulierten Strahlentherapie (IMRT) mittels helikaler Tomotherapie bei Kopf-Hals-Tumoren und die Berechnung der erforderlichen Sicherheitssäume (sm) aus den notwendigen Tischverschiebungen (ta).
Material und Methoden
Zwischen April und September 2016 wurden 15 Patienten mit Kopf-Hals-Tumoren mit der Hi-Art-II-Tomotherapy bestrahlt. Die prätherapeutische Patientenlagerung wurde regelmäßig anhand einer Megavolt-Computertomographie (MV-CT) beurteilt. Die notwendigen ta in Rechts-Links- (rl), superior-inferiorer (si) und anterior-posteriorer (ap) Richtung wurden für vier anatomische Punkte bestimmt: zweiter, vierter und sechster Halswirbelkörper (CVB), Spina nasalis anterior (ANS). Aus diesen Verschiebungen wurden die sm für nichtbildgestützte und bildgestützte (IGRT) Strahlentherapie sowie für IGRT basierend auf einem kürzeren MV-CT im Bereich CVB 2 berechnet.
Ergebnisse
Basierend auf dem Vergleich zum Planungs-CT ergab sich eine notwendige ta von –0,05 ± 1,31 mm für CVB 2 (ap) und bis zu 2,63 ± 2,39 mm für ANS (rl). Unter Beachtung der durchgeführten ta, die aus dem MV-CT resultierten, verblieb eine ta von –0,10 ± 1,09 mm für CVB 4 (rl) und bis zu 1,97 ± 1,64 mm für ANS (si). Nach theoretischer Optimierung der Patientenposition basierend auf CVB 2 verblieb eine ta von –0,11 ± 2,44 mm für CVB 6 (ap) und bis zu 2,37 ± 2,17 mm für ANS (si). Aus diesen Daten errechnete sm: nichtkorrigierte Patientenposition 3,63–9,95 mm, korrigierte Patientenposition basierend auf gesamtem Zielvolumen (IGRT) 1,85–6,63 mm, korrigierte Patientenposition basierend auf CVB 2 (IGRT) 3,13–6,66 mm.
Schlussfolgerung
Die errechneten sm unterscheiden sich zwischen anatomischen Regionen. Wiederholte und regelmäßige Kontrollen der Patientenposition sind notwendig, können allerdings eventuell auf eine Region begrenzt werden.
Similar content being viewed by others
References
van Herk M, Remeijer P, Rasch C et al (2000) The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 47(4):1121–1135
Jeon W, Wu HG, Song SH, Kim JI (2012) Radial displacement of clinical target volume in node negative head and neck cancer. Radiat Oncol J 30(1):36–42
Hou WH, Wang CW, Tsai CL et al (2016) The ratio of weight loss to planning target volume significantly impacts setup errors in nasopharyngeal cancer patients undergoing helical tomotherapy with daily megavoltage computed tomography. Radiol Oncol 50(4):427–432
Zhou J, Uhl B, Dewit K et al (2010) Analysis of daily setup variation with tomotherapy megavoltage computed tomography. Med Dosim 35(1):31–37
Thondykandy B, Swamidas J, Agarwal J et al (2015) Setup error analysis in helical tomotherapy based image-guided radiation therapy treatments. J Med Phys 40(4):233–239
Zhang L, Garden AS, Lo J et al (2006) Multiple regions-of-interest analysis of setup uncertainties for head-and-neck cancer radiotherapy. Int J Radiat Oncol Biol Phys 64(5):1559–1569
Su J, Chen W, Yang H et al (2015) Different setup errors assessed by weekly cone-beam computed tomography on different registration in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Onco Targets Ther 8:2545–2553
Mukai Y, Janssen S, Glanzmann C et al (2017) Local control and intermediate-term cosmetic outcome following IMRT for nasal tumors : an update. Strahlenther Onkol 193(4):295–304. https://doi.org/10.1007/s00066-016-1083-8
Ursino S, D’Angelo E, Mazzola R et al (2017) A comparison of swallowing dysfunction after three-dimensional conformal and intensity-modulated radiotherapy. A systematic review by the Italian head and neck radiotherapy study group. Strahlenther Onkol. https://doi.org/10.1007/s00066-017-1160-7
McQuaid D, Dunlop A, Nill S et al (2016) Evaluation of radiotherapy techniques for radical treatment of lateralised oropharyngeal cancers: dosimetry and NTCP. Strahlenther Onkol 192(8):516–525
Hong TS, Tomé WA, Chappell RJ et al (2005) The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 61(3):779–788
Astreinidou E, Bel A, Raaijmakers CP et al (2005) Adequate margins for random setup uncertainties in head-and-neck IMRT. Int J Radiat Oncol Biol Phys 61(3):938–944
Samuelsson A, Mercke C, Johansson KA (2003) Systematic set-up errors for IMRT in the head and neck region: effect on dose distribution. Radiother Oncol 66(3):303–311
Suzuki M, Nishimura Y, Nakamatsu K et al (2006) Analysis of interfractional set-up errors and intrafractional organ motions during IMRT for head and neck tumors to define an appropriate planning target volume (PTV)- and planning organs at risk volume (PRV)-margins. Radiother Oncol 78(3):283–290
Ove R, Cavalieri R, Noble D, Russo SM (2012) Variation of neck position with image-guided radiotherapy for head and neck cancer. Am J Clin Oncol 35(1):1–5
Wellner S (2017) Patientendosis durch MVCT Lagerungskontrolle unter helikaler Tomotherapie. Masterthesis, Heinrich Heine Universität Düsseldorf
van Kranen S, van Beek S, Rasch C et al (2009) Setup uncertainties of anatomical sub-regions in head-and-neck cancer patients after offline CBCT guidance. Int J Radiat Oncol Biol Phys 73(5):1566–1573
Park ET, Park SK (2016) Setup uncertainties for inter-fractional head and neck cancer in radiotherapy. Oncotarget 7(29):46662–46667
Schwartz DL (2012) Current progress in adaptive radiation therapy for head and neck cancer. Curr Oncol Rep 14(2):139–147
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
C. Leitzen, T. Wilhelm-Buchstab, T. Müdder, M. Heimann, D. Koch, C. Schmeel, B. Simon, S. Stumpf, S. Vornholt, S. Garbe, F. Röhner, F. Schoroth, H.H. Schild and H. Schüller declare that they have no competing interests.
Ethical standards
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Christina Leitzen and Timo Wilhelm-Buchstab contributed equally to the manuscript.
Rights and permissions
About this article
Cite this article
Leitzen, C., Wilhelm-Buchstab, T., Müdder, T. et al. Patient positioning in head and neck cancer. Strahlenther Onkol 194, 386–391 (2018). https://doi.org/10.1007/s00066-018-1265-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-018-1265-7